Evidence map›Paper›PMID 37086029›Full record

ArticleMolecular microbiology2023

c-di-GMP regulates activity of the PlzA RNA chaperone from the Lyme disease spirochete.

Taylor Van Gundy, Dhara Patel, Bruce E Bowler, Michael T Rothfuss, Allie J Hall, Christopher Davies, Laura S Hall, Dan Drecktrah, Richard T Marconi, D Scott Samuels and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. TheInfection and immunity · 2026
    Article
  4. The BosR Is Back!Molecular microbiology · 2026
    Article
  5. Virulence Regulation inMicroorganisms · 2025
    Review
  6. Article
  7. bioRxiv : the preprint server for biology · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Taylor Van GundyBacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Center for Disease Control and Prevention, Fort Collins, Colorado, USA.
Dhara PatelDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.
Bruce E BowlerDepartment of Chemistry and Biochemistry, University of Montana, Missoula, Montana, USA.
Michael T RothfussDepartment of Chemistry and Biochemistry, University of Montana, Missoula, Montana, USA.
Allie J HallBacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Center for Disease Control and Prevention, Fort Collins, Colorado, USA.
Christopher DaviesDepartment of Biochemistry and Molecular Biology, University of South Alabama, Mobile, Alabama, USA.
Laura S HallDivision of Biological Sciences, University of Montana, Missoula, Montana, USA.
Dan DrecktrahDivision of Biological Sciences, University of Montana, Missoula, Montana, USA.
Richard T MarconiDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.
D Scott SamuelsCenter for Biomolecular Structure and Dynamics, University of Montana, Missoula, Montana, USA.ORCID 0000-0001-8352-7593
Meghan C LybeckerBacterial Diseases Branch, Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Center for Disease Control and Prevention, Fort Collins, Colorado, USA.ORCID 0000-0002-4861-1463
University of Montana · USNational Center for Emerging and Zoonotic Infectious Diseases · USVirginia Commonwealth University Medical Center · USUniversity of South Alabama · US

Funding

PlzA, cyclic-di-GMP and the enzootic cycle for Lyme diseaseU01AI169840 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI Christopher Davies, RICHARD T MARCONI · 2023 to 2026
$2.8M
Regulation of glycerol utilization in Borrelia burgdorferiR01AI130247 · NIAID · UNIVERSITY OF MONTANA · PI DRECKTRAH, DAN, SAMUELS, D. SCOTT · 2018 to 2022
$2.2M
NIAID NIH HHS R01 AI130247NIAID NIH HHS U01 AI169840
6 · The paper itself

Abstract

PlzA is a c-di-GMP-binding protein crucial for adaptation of the Lyme disease spirochete Borrelia (Borreliella) burgdorferi during its enzootic life cycle. Unliganded apo-PlzA is important for vertebrate infection, while liganded holo-PlzA is important for survival in the tick; however, the biological function of PlzA has remained enigmatic. Here, we report that PlzA has RNA chaperone activity that is inhibited by c-di-GMP binding. Holo- and apo-PlzA bind RNA and accelerate RNA annealing, while only apo-PlzA can strand displace and unwind double-stranded RNA. Guided by the crystal structure of PlzA, we identified several key aromatic amino acids protruding from the N- and C-terminal domains that are required for RNA-binding and unwinding activity. Our findings illuminate c-di-GMP as a switch controlling the RNA chaperone activity of PlzA, and we propose that complex RNA-mediated modulatory mechanisms allow PlzA to regulate gene expression during both the vector and host phases of the B. burgdorferi life cycle.

Indexed as

Borrelia burgdorferiBorrelia burgdorferi GroupIxodesLyme DiseaseBacterial ProteinsCyclic GMPRNABacterial Proteinsbis(3',5')-cyclic diguanylic acidCyclic GMPRNABorrelia burgdorferic-di-GMPLyme diseasePlzARNA chaperone

Identifiers

PMID37086029
PMCPMC10330241
OpenAlexW4366742604

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.